{name}
{subtitle}
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~80 mi. (Belfast, United Kingdom, +199 more cities)
facility
Belfast City Hospital ( Site 0752)
International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
city
~80 mi. (Belfast, United Kingdom, +61 more cities)
facility
Royal Belfast Hospital for Sick Children
condition
Acute Myeloid Leukemia, +2 more conditions
drug
busulfan, +4 more drugs
drug type
chemotherapy, +1 more type
An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.
city
~80 mi. (Belfast, United Kingdom, +52 more cities)
facility
Investigational Site
drug
AB680, +4 more drugs
drug type
chemotherapy, +2 more types
A Study to Learn How Safe the Study Drug BAY 2416964 (AhR Inhibitor) in Combination With the Treatment Pembrolizumab is, How This Combination Affects the Body, the Maximum Amount That Can be Given, How it Moves Into, Through and Out of the Body and Its Action Against Advanced Solid Cancers in Adults
city
~80 mi. (Belfast, United Kingdom, +11 more cities)
facility
Belfast City Hospital
drug
BAY2416964, +1 more drug
PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition and/or Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Chemotherapy Resistant Residual Triple Negative Breast Cancer
city
~80 mi. (Belfast, United Kingdom, +8 more cities)
facility
Belfast City Hospital
biomarker
ER Negative, +2 more biomarkers
drug
ceralasertib, +2 more drugs
drug type
immunotherapy, +1 more type
INTERVAL - Intense Exercise Trial for Men With Metastatic Castrate-Resistant Prostate Cancer
city
~80 mi. (Belfast, United Kingdom, +2 more cities)
facility
Queens University Belfast
A Study to Assess the Efficacy and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
city
~95 mi. (Deer Park, Ireland, +84 more cities)
facility
Site IR35301
drug
gemcitabine, +2 more drugs
drug type
chemotherapy, +1 more type
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer
city
~96 mi. (Dublin, Ireland, +247 more cities)
facility
St. James'S Hospital
biomarker
ER Positive, +1 more biomarker
drug
anthracycline, +4 more drugs
drug type
chemotherapy, +2 more types